Detalhe da pesquisa
1.
Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review.
Curr Treat Options Oncol
; 24(9): 1259-1273, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407887
2.
Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Cancer Invest
; 39(10): 871-879, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643126
3.
Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.
Haematologica
; 106(1): 284-287, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079693
4.
Ibrutinib-induced pneumonitis in patients with chronic lymphocytic leukemia.
Blood
; 127(8): 1064-7, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26702066
5.
Pan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse.
Leuk Lymphoma
; 62(11): 2690-2702, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355654
6.
Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther
; 27(9): 784.e1-784.e7, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34146734
7.
Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
Transplant Cell Ther
; 27(8): 669.e1-669.e8, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991725
8.
Utilizing Real-World Evidence (RWE) to Improve Care in Chronic Lymphocytic Leukemia: Challenges and Opportunities.
Curr Hematol Malig Rep
; 15(4): 254-260, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382987
9.
Real-World Evidence for Chronic Lymphocytic Leukemia in the Era of Targeted Therapies.
Cancer J
; 25(6): 442-448, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31764126
10.
Small-molecule nicotinamide for ex vivo expansion of umbilical cord blood.
Exp Hematol
; 80: 11-15, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786243
11.
PET-derived tumor metrics predict DLBCL response and progression-free survival.
Leuk Lymphoma
; 60(8): 1965-1971, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30714446
12.
Tailored Treatment Strategies for Chronic Lymphocytic Leukemia in a Rapidly Changing Era.
Am Soc Clin Oncol Educ Book
; 39: 487-498, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31099686